Matthew Bowen
Principal Accounting Officer, Monte Rosa Therapeutics.
Companies
- Monte Rosa TherapeuticsPrincipal Accounting Officer Apr 7, 2026 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Monte Rosa Therapeutics GLUE21,604 shares2$218.6K at $10.12Apr 7, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 6, 2026Granted 4,300 shares of Monte Rosa Therapeutics3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Apr 7, 2026